GI
SGMO

Gradient Investments’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Gradient Investments’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-181
Closed -$2K – 785
2015
Q4 		$2K Sell
181
-694
-79% -$5.35K ﹤0.01% 596
2015
Q3 		$5K Sell
875
-27,252
-97% -$225K ﹤0.01% 458
2015
Q2 		$312K Buy
28,127
+717
+3% +$9.24K 0.04% 155
2015
Q1 		$430K Buy
+27,410
New +$424K 0.06% 136

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Gradient Investments's SGMO Position: Q1 2016 in Review

Gradient Investments sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2016, closing a stake of 181 shares — an estimated $2K sold.

Gradient Investments first reported a position in SGMO in Q1 2015 and held it in 4 quarters. The position peaked at $430K in Q1 2015. 143 funds tracked by Wall St. Rank hold SGMO as of Q1 2016.

  • Gradient Investments reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2016 after selling out during the quarter.
  • Gradient Investments sold 181 SANGAMO THERAPEUTICS INC shares in Q1 2016, an estimated $2K.
  • Gradient Investments first reported a position in SANGAMO THERAPEUTICS INC in Q1 2015 and held it in 4 quarters.
  • Gradient Investments's SANGAMO THERAPEUTICS INC position peaked at $430K in Q1 2015.
  • 143 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2016.

Based on Gradient Investments's 13F filing for Q1 2016, filed 13 Apr 2016.